COMMUNIQUÉS West-GlobeNewswire

Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
09/10/2025
– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in cognition and behavior at 2 years; results contrast with minimal change in natural [...]
Shuttle to Enter $3.24 Billion AI Pharmaceutical Market
09/10/2025
GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today [...]
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
09/10/2025
SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, [...]
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
09/10/2025
MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
09/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance
09/10/2025
Company to host conference call today, October 9th, 2025, to discuss the financial results and updated outlook WARSAW, Ind., Oct. 09, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) ( [...]
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/10/2025
REDWOOD CITY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today [...]
Procedure of the Annual General Meeting
09/10/2025
ANNOUNCEMENT NO. 294 9 October 2025 Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was held on 9 October 2025 at 5.30 p.m. at Nordsjællands KonferenceCenter. At the Annual General [...]
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
09/10/2025
Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical data at EADV 2025 for GS-6791 (NX-0479), a novel IRAK4 [...]
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
09/10/2025
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced [...]
Executive Wellness Retreats: Grey Matters International Announces Expansion of Neuroscience-Based Programs
09/10/2025
Tulsa, Oklahoma , Oct. 09, 2025 (GLOBE NEWSWIRE) -- Grey Matters International, Inc. , a neuroscience-driven mental health organization founded by Kevin J. Fleming, Ph.D., today announced the expansion of its executive [...]
Academy Award-Winning Actress Helen Hunt to Headline Methodist Healthcare Foundation Luncheon
09/10/2025
Memphis, Tenn., Oct. 09, 2025 (GLOBE NEWSWIRE) -- The Methodist Healthcare Foundation will welcome Academy Award-winning actress and breast cancer advocate Helen Hunt as the featured speaker for its annual Luncheon on [...]
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
09/10/2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT) [...]
Childhood Cancer Deserves Year-Round Commitment to Funding and Research
09/10/2025
Mothers channel loss into a $1.5 million commitment to fund childhood cancer research. HOUSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Five mothers who each lost a child to Ewing sarcoma, an aggressive pediatric cancer, have [...]
JOURTHON® Launches Brain Health Softgel
09/10/2025
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Memory lapses, poor concentration, and mental fatigue are no longer just signs of aging. Today, they affect professionals, entrepreneurs, and parents across all stages of life [...]
Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
09/10/2025
– Complete B cell depletion, rapid reduction in autoantibodies and near-complete resolution of clinical symptoms in two of three refractory patients; all three patients remained off immunomodulators since infusion and [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025
09/10/2025
Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2025
09/10/2025
Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris [...]
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
09/10/2025
Announcement no. 09/2025 Inside information Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting Coloplast interim CEO Lars Rasmussen has today informed the Coloplast [...]

Pages